MétaCan
Menu
Retour à la cohorte
Enregistrement W2410777433 · doi:10.1111/j.1399-5448.2009.00577.x

Introduction

2009· article· en· W2410777433 sur OpenAlexaboutno aff
Ragnar Hanås, Kim C. Donaghue, Georgeanna J. Klingensmith, Peter G.F. Swift

Notice bibliographique

RevuePediatric Diabetes · 2009
Typearticle
Langueen
DomaineMedicine
ThématiqueDiabetes Management and Research
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicine

Résumé

récupéré en direct d'OpenAlex

This supplement of Pediatric Diabetes is the compendium of guidelines chapters published 2006–2008 as individual articles in Pediatric Diabetes, which are available on ISPAD's website www.ispad.org. The guidelines have been modified and updated to reflect major new evidence published since they were published previously. In 2007, the total child population of the world (0–14 years) was estimated to be 1.8 billion, of whom 0.02% have diabetes. This means that approximately 440,000 children around the world have diabetes with 70,000 new cases diagnosed each year 1. However, field data would suggest that some individual country estimates (especially in Africa) are over-estimated. This very large number of children need help to survive with injections of insulin to live a full life without restrictions or disabling complications and without being stigmatized for their diabetes. Even today, almost a century after the discovery of insulin, the most common cause of death in a child with diabetes from a global perspective is lack of access to insulin 2. Many children die before their diabetes is diagnosed. It is therefore of utmost importance that all forces unite to make it come true that no child should die from diabetes. A promising initiative has been taken by IDF/Life for a Child (www.lifeforachild.org) in collaboration with ISPAD and other organizations (Access to Essential Diabetes Medicines for Children in the Developing World). Several major companies that produce insulin and other diabetes supplies have pledged their support, and the numbers of children provided with insulin will according to plan increase to approximately 12,000 in 2010 and 30,000 by 2015. ISPAD has pledged structural support and assistance in the training of paediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network. In 1993, members of the International Society for Pediatric and Adolescent Diabetes (ISPAD) formulated the Declaration of Kos, proclaiming their commitment to "promote optimal health, social welfare and quality of life for all children with diabetes around the world by the year 2000." Although all the aims and ideals of the Declaration of Kos had not been reached by 2000, we feel that slowly, by small steps, the worldwide care of children is improving. ISPAD published its first set of guidelines in 1995 3 and its second in 2000 4. Since then, the acceptance of intensive therapy, also for very young children, has increased around the world. Insulin pump usage has risen in all age groups in countries where this treatment modality can be afforded. Intensive therapy requires better and more comprehensive education for it to be successful. The ISPAD Consensus Guidelines 2000 has been translated into 11 languages, indicating the need for a truly international document. In 2003–2005, national guidelines for childhood diabetes have been released: the Australian Clinical Practice Guidelines from the National Health and Medical Research Council, (Writing Committee Chair, Martin Silink) 5; in the United Kingdom, the National Institute for Clinical Excellence (NICE) Clinical Guideline (Group Leader Stephen Greene) 6. Both these publications are truly evidence-based in that they deal with the body of evidence with a systematic approach, grading each reference and building the case for each recommendation. In 2003 the Canadian Diabetes Association published Clinical Practice Guidelines with chapters both on type 1 and type 2 in children and adolescents 7. In 2005, the American Diabetes Association (ADA) published their statement on the care of children and adolescents with type 1 diabetes 8. This updated third edition of ISPAD's Consensus Guidelines, now Clinical Practice Consensus Guidelines is much larger, and has been enriched by the above mentioned national guidelines. In the Introduction to the 2000 ISPAD Guidelines the acknowledged intention was for the next guidelines to be referenced. We have used the ADA grading system for grading evidences 9. Whenever possible, the reference for a statement or recommendation has been included, but as the reader will see, a vast majority of the recommendations and suggestions do have the grade E (Expert consensus or clinical experience). The updated 2009 guidelines are based on a wide consensus of clinical practice. They were drafted by international writing teams, modified by experts in different specialties from many countries, debated at the annual ISPAD meetings in 2005–2008 by the members, and were reviewed by members via the Internet and the ISPAD website. As far as possible, significant input by individuals has been acknowledged. Many thanks to the large number of individuals who have contributed but whose names could not be included. The American Diabetes Association evidence grading system for clinical practice recommendations is as follows: As the 2000 Guidelines, the 2006–2008 Guidelines and the 2009 Compendium places education at the center of clinical management. Education is the vehicle for optimal self-management, the key to success. New chapters have been added on type 2 diabetes in children and adolescents, monogenic diabetes, exercise and cystic fibrosis related diabetes. We hope therefore that the guidelines will be widely consulted and will be used to: improve awareness among governments, state health care providers and the general public of the serious long-term implications of poorly managed diabetes and of the essential resources needed for optimal care assist individual care givers in managing children and adolescents with diabetes in a prompt, safe, consistent, equitable, standardized manner in accordance with the current views of experts in the field. As in 2000, "these guidelines are not strict protocols nor are they the final word". Individual clinical judgment and decision making also require the family's values and expectations to be considered with the best outcomes being reached by consensus. Conflicts of interest: the editors have declared no conflicts of interest. Ragnar Hanas a Kim C. Donaghue a Georgeanna Klingensmith a Peter G.F. Swift a

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,008
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesCharge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesCharge utile insuffisante (le modèle a refusé de juger)
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Éditorial · Signal consensuel: aucune
Score de désaccord entre enseignants0,518
Score d'incertitude au seuil0,738

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0010,008
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0010,001
Bibliométrie0,0010,001
Études des sciences et des technologies0,0010,001
Communication savante0,0050,003
Science ouverte0,0020,003
Intégrité de la recherche0,0030,003
Charge utile insuffisante (le modèle a refusé de juger)0,4820,310

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,008
Tête enseignante GPT0,258
Écart entre enseignants0,250 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; l’étiquette directe de Gemma et le classifieur distillé Codex s’accordent sur ce qui est montré ici.

Devis d'étudeSans objet
Domainenon disponible
GenreÉditorial

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations57
Publié2009
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revuePediatric DiabetesMême sujetDiabetes Management and ResearchTravaux en français237 207